Search results for "Keeping tabs"


 
Results 1 - 10 of about 138 for "Keeping tabs".
Sort by: Relevance | Newest | Oldest

Spotlight on gut microbiota in diabetes

A forum and a narrative review summarized current knowledge about the connections between diabetes and gut microbiota, while a new study identified certain species within patients' microbiomes that could relate to diabetes.
https://diabetes.acponline.org/archives/2024/07/12/5.htm
12 Jul 2024

Spotlight on NAFLD

Recent studies looked at the risks associated with nonalcoholic fatty liver disease (NAFLD), also known as metabolic dysfunction-associated steatotic liver disease (MASLD), the effects of diabetes drugs on the condition, and whether machine learning can help identify patients at risk.
https://diabetes.acponline.org/archives/2024/03/08/5.htm
8 Mar 2024

Spotlight on technology for pregnant diabetes patients

Studies of continuous glucose monitoring in pregnant patients with type 1 or 2 diabetes highlighted the effects of time in range on neonatal outcomes, while two others tested automated insulin delivery during pregnancy in type 1 diabetes patients.
https://diabetes.acponline.org/archives/2023/10/13/5.htm
13 Oct 2023

Spotlight on limitations of the HbA1c test

A recent position statement called for use of one-hour glucose tolerance testing for diabetes diagnosis, a review described limitations of point-of-care HbA1c testing, and a study identified differences in the relationship between fasting glucose and HbA1c level by race, age, and sex.
https://diabetes.acponline.org/archives/2024/04/12/5.htm
12 Apr 2024

Spotlight on glycemia and dementia

One study found reduced rates of dementia in patients with type 2 diabetes who took metformin, while another showed that impaired fasting glucose posed a cognitive risk, and a review compared diabetes drug classes for their effects on dementia risk.
https://diabetes.acponline.org/archives/2023/12/08/5.htm
8 Dec 2023

Spotlight on statins in diabetes

Recent studies looked at how statins negatively affect glycemic control but improve cardiovascular mortality, as well as the reasons patients with diabetes don't receive prescriptions for statins despite recommendations.
https://diabetes.acponline.org/archives/2023/04/14/5.htm
14 Apr 2023

Spotlight on the 2024 Standards of Care

The American Diabetes Association made its annual updates to the Standards of Care in Diabetes, addressing newer drug classes and growing evidence for bariatric surgery and heart failure screening, among many other changes.
https://diabetes.acponline.org/archives/2024/01/12/5.htm
12 Jan 2024

Spotlight on comparisons within diabetes drug classes

One review found tirzepatide to have more effect on glycemic outcomes than other glucagon-like peptide-1 receptor agonists, while another showed several sodium-glucose cotransporter-2 inhibitors to have similar effects on cardiovascular outcomes.
https://diabetes.acponline.org/archives/2024/02/09/5.htm
9 Feb 2024

Spotlight on novel therapies for type 1 diabetes

Manufacturer trials reported the effects of weekly insulin and teplizumab in patients with type 1 diabetes, while recent reviews looked at preventing beta-cell loss with various therapeutics and using drugs approved for type 2 diabetes to combat chronic kidney disease in type 1.
https://diabetes.acponline.org/archives/2023/11/10/5.htm
10 Nov 2023

Spotlight on weight loss drugs

The American Society of Anesthesiologists released guidance on preoperative management of glucagon-like peptide-1 receptor agonists, and recent studies looked at the effects of semaglutide, retatrutide, and orforglipron on weight in patients with and without diabetes.
https://diabetes.acponline.org/archives/2023/07/14/5.htm
14 Jul 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next